NO154057C - Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-halogenderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-halogenderivater.

Info

Publication number
NO154057C
NO154057C NO801236A NO801236A NO154057C NO 154057 C NO154057 C NO 154057C NO 801236 A NO801236 A NO 801236A NO 801236 A NO801236 A NO 801236A NO 154057 C NO154057 C NO 154057C
Authority
NO
Norway
Prior art keywords
isopropylamino
pyrimidine
preparation
therapeutically active
halogen derivatives
Prior art date
Application number
NO801236A
Other languages
English (en)
Other versions
NO801236L (no
NO154057B (no
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10505180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO154057(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of NO801236L publication Critical patent/NO801236L/no
Publication of NO154057B publication Critical patent/NO154057B/no
Publication of NO154057C publication Critical patent/NO154057C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO801236A 1979-05-15 1980-04-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-halogenderivater. NO154057C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7916918 1979-05-15

Publications (3)

Publication Number Publication Date
NO801236L NO801236L (no) 1980-11-17
NO154057B NO154057B (no) 1986-04-01
NO154057C true NO154057C (no) 1986-07-09

Family

ID=10505180

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801236A NO154057C (no) 1979-05-15 1980-04-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-halogenderivater.

Country Status (30)

Country Link
US (1) US4267181A (no)
JP (1) JPS55151571A (no)
AR (1) AR222872A1 (no)
AT (1) AT375074B (no)
AU (1) AU529581B2 (no)
BE (1) BE882836A (no)
CA (1) CA1132562A (no)
CH (1) CH645103A5 (no)
DE (1) DE3016549C2 (no)
DK (1) DK183980A (no)
EG (1) EG14260A (no)
ES (1) ES491004A0 (no)
FI (1) FI68045C (no)
FR (2) FR2456521A1 (no)
HK (1) HK55483A (no)
IE (1) IE49708B1 (no)
IN (1) IN154370B (no)
IT (1) IT1148798B (no)
LU (1) LU82379A1 (no)
MA (1) MA18825A1 (no)
MX (1) MX6295E (no)
MY (1) MY8400201A (no)
NL (1) NL8002421A (no)
NO (1) NO154057C (no)
NZ (1) NZ193533A (no)
OA (1) OA06526A (no)
PT (1) PT71162A (no)
SE (1) SE435177B (no)
SG (1) SG22483G (no)
ZA (1) ZA802375B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US4868161A (en) * 1984-06-29 1989-09-19 City Of Hope Method for promoting nerve regeneration
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2436360A (en) * 1948-02-17 Preparation of z-amino-s-chloro
US2609372A (en) * 1950-05-05 1952-09-02 Sharp & Dohme Inc Halogenation of 2-aminopyrimidines
US3984414A (en) * 1971-10-09 1976-10-05 Societe D'etudes De Produits Chimiques Dichloroacetate salt of 2-isopropylamino pyrimidine
BE788648A (fr) * 1971-10-09 1973-01-02 Soc D Etudes Prod Chimique Derives de l'isopropylamino pyrimidine, leur preparation leur composition et leur utilisation therapeutique
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
CH645103A5 (fr) 1984-09-14
LU82379A1 (fr) 1980-07-31
FI801330A (fi) 1980-11-16
NO801236L (no) 1980-11-17
NZ193533A (en) 1982-03-23
FR2456734A1 (fr) 1980-12-12
FR2456521A1 (fr) 1980-12-12
DE3016549A1 (de) 1980-11-27
FR2456521B1 (no) 1982-10-01
JPS6251271B2 (no) 1987-10-29
BE882836A (fr) 1980-08-18
SG22483G (en) 1983-12-16
EG14260A (en) 1983-09-30
DK183980A (da) 1980-11-16
IE49708B1 (en) 1985-11-27
ATA221480A (de) 1983-11-15
AU529581B2 (en) 1983-06-09
ZA802375B (en) 1981-06-24
MA18825A1 (fr) 1980-12-31
PT71162A (en) 1980-05-01
NO154057B (no) 1986-04-01
AR222872A1 (es) 1981-06-30
FI68045C (fi) 1985-07-10
OA06526A (fr) 1981-07-31
SE8003241L (sv) 1980-11-16
MX6295E (es) 1985-03-18
IT8021641A0 (it) 1980-04-24
ES8104252A1 (es) 1981-04-01
SE435177B (sv) 1984-09-10
IE800862L (en) 1980-11-15
IN154370B (no) 1984-10-20
AT375074B (de) 1984-06-25
ES491004A0 (es) 1981-04-01
FR2456734B1 (no) 1982-10-08
CA1132562A (en) 1982-09-28
DE3016549C2 (de) 1987-01-22
IT1148798B (it) 1986-12-03
HK55483A (en) 1983-11-25
JPS55151571A (en) 1980-11-26
NL8002421A (nl) 1980-11-18
US4267181A (en) 1981-05-12
AU5779080A (en) 1980-11-20
FI68045B (fi) 1985-03-29
MY8400201A (en) 1984-12-31

Similar Documents

Publication Publication Date Title
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO154054C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO154057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-halogenderivater.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.